LLY
998.47
-0.25%↓
JNJ
244.74
-0.11%↓
ABBV
233.46
+0.78%↑
NVS
163.54
+1.89%↑
AZN
202.13
+2.34%↑
LLY
998.47
-0.25%↓
JNJ
244.74
-0.11%↓
ABBV
233.46
+0.78%↑
NVS
163.54
+1.89%↑
AZN
202.13
+2.34%↑
LLY
998.47
-0.25%↓
JNJ
244.74
-0.11%↓
ABBV
233.46
+0.78%↑
NVS
163.54
+1.89%↑
AZN
202.13
+2.34%↑
LLY
998.47
-0.25%↓
JNJ
244.74
-0.11%↓
ABBV
233.46
+0.78%↑
NVS
163.54
+1.89%↑
AZN
202.13
+2.34%↑
LLY
998.47
-0.25%↓
JNJ
244.74
-0.11%↓
ABBV
233.46
+0.78%↑
NVS
163.54
+1.89%↑
AZN
202.13
+2.34%↑
24h
Corrente
Minimo
3
Massimo
3.29
Raccomandazioni | Acquista |
|---|---|
Previsioni per 12 mesi | +415.15% upside |
Utili prossimi | 27 mar 2026 |
|---|
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
15 dic 2025, 16:30 UTC
Fortress Biotech Rises After FDA Accepts Application for Menkes Treatment
DJ
LeggI
1 ott 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
LeggI
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
LeggI
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
LeggI
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
LeggI
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
LeggI
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
LeggI
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
LeggI
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
LeggI
Modifica del prezzo
By TipRanks
Previsioni per 12 mesi
Media 17 USD 415.15%
Alto 17 USD
Basso 17 USD
Basato su 1 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Fortress Biotech Inc - Dist negli ultimi 3 mesi.
By TipRanks
Acquista
1 ratings
1
Acquista
0
Mantieni
0
Vendi
Basato sugli analisti di 1 che hanno fornito valutazioni azionarie a Fortress Biotech Inc - Dist negli ultimi 3 mesi.
$